Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05OTL
|
|||
| Former ID |
DIB008783
|
|||
| Drug Name |
NW-3509
|
|||
| Synonyms |
NW-3381; Sodium channel blockers (epilepsy/pain/mania), Newron
Click to Show/Hide
|
|||
| Indication | Schizophrenia [ICD-11: 6A20] | Phase 2 | [1] | |
| Company |
Newron pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Sodium channel unspecific (NaC) | Target Info | Blocker | [2] |
| KEGG Pathway | Dopaminergic synapse | |||
| Reactome | Interaction between L1 and Ankyrins | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of Newron. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.